Status:
WITHDRAWN
Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
Lead Sponsor:
Sheba Medical Center
Conditions:
Familial Mediterranean Fever
Eligibility:
All Genders
18+ years
Brief Summary
Familial Mediterranean fever (FMF) is a genetic disease, caused by mutations in the FMF gene, entitled MEFV. The disease is characterized by painful attacks of inflammation in sites lined by serous me...
Detailed Description
Familial Mediterranean fever (FMF) is a genetic disease, caused by mutations in the FMF gene, entitled MEFV. The disease is characterized by painful attacks of inflammation in sites lined by serous me...
Eligibility Criteria
Inclusion
- FMF patients, agreeing with diagnostic criteria, in attack or remission, under or without colchicine treatment.
- Age 18 or older
- Male or female
- all ethnic groups arriving for treatment or routine follow up appointment
- Written Consent to participate and donate blood for protein, RNA and DNA analyses.
Exclusion
- Younger than 18
- Patients that use anti inflammatory medications, other than colchicine
- Patients who in addition to FMF suffer from another acute infectious or inflammatory disease
- Patients who in addition to FMF suffer from another chronic infectious or inflammatory or autoimmune disease.
- Amyloidosis
- Pregnancy
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00323440
Start Date
August 1 2008
End Date
August 1 2016
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel, 52621